Keywords: Dr Reddy's, OctoPlus, M&A, Drug delivery technology

India's Dr Reddy's to acquire OctoPlus for $35.7 million

Article | 22 October 2012

Print This

India’s second largest drugmaker Dr Reddy’s Laboratories (NYSE: RDY) announced this morning that it intendeds to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in